Page last updated: 2024-10-29

ifosfamide and Adenocarcinoma, Basal Cell

ifosfamide has been researched along with Adenocarcinoma, Basal Cell in 157 studies

Research Excerpts

ExcerptRelevanceReference
"There are currently no approved therapies for patients with metastatic pancreatic adenocarcinoma previously treated with gemcitabine."9.14A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine. ( Bodoky, G; Ciuleanu, TE; Garin, AM; Kroll, S; Langmuir, VK; Pavlovsky, AV; Tidmarsh, GT, 2009)
"Fifty-two patients with advanced adenocarcinoma of the endometrium recurrent after surgery and/or radiation therapy and refractory to first-line chemotherapeutic agents were treated with ifosfamide, 1."9.07Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study. ( Adcock, L; Blessing, JA; Homesley, HD; McGuire, WP; Sutton, GP, 1994)
"A phase II trial of ifosfamide (IFX) and mesna was conducted by the GOG in patients with recurrent or advanced nonsquamous carcinoma of the cervix."9.07Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study. ( Blessing, JA; DiSaia, PJ; McGuire, WP; Sutton, GP, 1993)
"We report the effectiveness of a combination chemotherapy consisting of ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus."7.74Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus. ( Fujii, Y; Fukui, I; Ishikawa, Y; Kawakami, S; Komai, Y; Okubo, Y; Takeshita, H; Tatokoro, M; Yamamoto, S; Yonese, J, 2008)
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide."7.74[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008)
"In advanced adenocarcinoma of the pancreas treatment with 5-fluorouracil (5-FU) or ifosfamide results in response rates of approximately 20%."7.69Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas. ( Bakker, PJ; Gouma, DJ; Huizing, MT; Poorter, RL; Rauws, EA; Rietbroek, RC; Taat, CW; Veenhof, CH, 1995)
" An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide."7.68Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991)
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1."7.68[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991)
"25 previously untreated patients with inoperable or metastatic adenocarcinoma of the oesophagus or oesophageal-gastric junction area were treated with ifosfamide 6 g/m2 over 48 hours, combined with mesna 6 g/m2."7.68Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group. ( Kok, TC; Splinter, TA; Tilanus, HW; van der Gaast, A, 1991)
"Fourteen evaluable patients with gynecologic adenocarcinoma (7 ovarian, 4 endometrial, 2 peritoneal and one breast cancer) were treated with ifosfamide (1 g/m2 X 5 days), adriamycin (50 mg/m2) and cisplatin (50 mg/m2) combined chemotherapy (IAP)."7.67Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin. ( Nagasue, N; Nishida, T, 1988)
"Nineteen patients with hormonal refractory adenocarcinoma of the prostate were treated with ifosfamide (IFM) and the combination of vincristine, ifosfamide and peplomycin (VIP)."7.67[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. ( Ebisui, K; Fujiwara, M; Kobayashi, T; Miyakoda, K; Nakagawa, S; Nakao, M; Nukui, M; Takada, H; Toyoda, K; Watanabe, H, 1989)
"From April 1982, until February 1984, 29 patients with biopsy-proven and measurable adenocarcinoma of the pancreas were treated with ifosfamide."7.67Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas. ( Ansari, R; Einhorn, LH; Loehrer, PJ; Williams, SD, 1985)
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)."7.66[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983)
" Alternative dosing of glufosfamide plus gemcitabine should be explored."6.75A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma. ( Barrios, CH; Chiorean, EG; Dragovich, T; Gorini, CF; Hamm, J; Jung, DT; Kroll, S; Langmuir, VK; Loehrer, PJ; Tidmarsh, GT, 2010)
"Phase I data indicate that full dose glufosfamide (4,500 mg/m(2)) can be given safely in combination with gemcitabine."6.73A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma. ( Chiorean, EG; Colowick, AB; Dragovich, T; Hamm, J; Jung, DT; Kroll, S; Langmuir, VK; Loehrer, PJ; Tidmarsh, GF, 2008)
"Local control rate for inflammatory breast cancer (IBC) is < 50% with standard chemotherapy-radiotherapy regimen."5.30Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. ( Boyages, J; Gurney, H; Harnett, P; Kefford, R, 1998)
"There are currently no approved therapies for patients with metastatic pancreatic adenocarcinoma previously treated with gemcitabine."5.14A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine. ( Bodoky, G; Ciuleanu, TE; Garin, AM; Kroll, S; Langmuir, VK; Pavlovsky, AV; Tidmarsh, GT, 2009)
" Thirty patients with poorly-differentiated carcinoma or poorly-differentiated adenocarcinoma (group A) received a combination of cisplatin and etoposide."5.09Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study. ( Borel, C; Ducreux, M; Fizazi, K; Le Chevalier, T; Ruffié, P; Saghatchian, M; Théodore, C, 2001)
"Fifty-two patients with advanced adenocarcinoma of the endometrium recurrent after surgery and/or radiation therapy and refractory to first-line chemotherapeutic agents were treated with ifosfamide, 1."5.07Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study. ( Adcock, L; Blessing, JA; Homesley, HD; McGuire, WP; Sutton, GP, 1994)
"A phase II trial of ifosfamide (IFX) and mesna was conducted by the GOG in patients with recurrent or advanced nonsquamous carcinoma of the cervix."5.07Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study. ( Blessing, JA; DiSaia, PJ; McGuire, WP; Sutton, GP, 1993)
"Herein we present a unique case report of a 47-year- old man with metastatic adenocarcinoma of rete testis who achieved substantial disease response after four cycles of paclitaxel, ifosfamide and cisplatin."3.80Adenocarcinoma of the rete testis - a rare case of testicular malignancy. ( Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Rajec, J; Sycova-Mila, Z, 2014)
"We report the effectiveness of a combination chemotherapy consisting of ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus."3.74Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus. ( Fujii, Y; Fukui, I; Ishikawa, Y; Kawakami, S; Komai, Y; Okubo, Y; Takeshita, H; Tatokoro, M; Yamamoto, S; Yonese, J, 2008)
" Three courses with cisplatin 75 mg/m(2), paclitaxel 175 mg/m(2) and ifosfamide 5 g/m(2) (epirubicin 80 mg/m(2) in adenocarcinoma) were followed by cold-knife conization and pelvic lymphadenectomy."3.74Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. ( Bonazzi, C; Chiari, S; Maneo, A; Mangioni, C, 2008)
"We report a patient with primary lung adenocarcinoma who had Ewing's sarcoma and was successfully treated with ifosfamide."3.74[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide]. ( Arai, H; Fukumura, H; Kudo, M; Masuda, M; Nakajima, K; Oshiro, H; Rino, Y; Wada, N; Watanuki, Y; Yamanaka, S; Yukawa, N, 2008)
" We report a patient who was cured of metastatic adenocarcinoma in Barrett's oesophagus by six courses of ifosfamide, a chemotherapeutic agent with little or no activity in other patients with adenocarcinoma of the oesophagus or gastro-oesophageal junction."3.71Cure of Barrett's carcinoma by ifosfamide chemotherapy. ( Hage, M; Kok, TC; Kuipers, EJ; Siersema, PD; Tilanus, HW; van Dekken, H; van der Gaast, A, 2002)
"In advanced adenocarcinoma of the pancreas treatment with 5-fluorouracil (5-FU) or ifosfamide results in response rates of approximately 20%."3.69Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas. ( Bakker, PJ; Gouma, DJ; Huizing, MT; Poorter, RL; Rauws, EA; Rietbroek, RC; Taat, CW; Veenhof, CH, 1995)
"The multidrug resistance gene product P-glycoprotein (P-GP) was assessed immunohistochemically (by antibody JSB-1) in biopsy specimens from 27 oesophageal squamous carcinomas and 10 adenocarcinomas before treatment with mitomycin, ifosfamide and cisplatin (MIC)."3.69Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. ( Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS, 1995)
"Patients with advanced adenocarcinoma of the lung with measurable or assessable disease received chemotherapy with mesna, ifosfamide, carboplatin, and etoposide (MICE)."3.69Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. ( Boerrigter, L; Mooi, WJ; Rodenhuis, S; Slebos, RJ; Top, B; van Zandwijk, N; van't Veer, L, 1997)
" An extension of the comparative study to the in vivo model of murine C3H mammary adenocarcinoma yielded synergistic effects, if the animals were treated with 10 MeV electrons and one of the drugs: cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide."3.68Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph ( Ulmer, W, 1991)
"Forty seven patients with inoperable adenocarcinoma and large cell carcinoma of the lung were treated with a combination of cisplatin (25 mg/m2), ifosfamide (1."3.68[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung]. ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Mori, T; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991)
"Of 13 patients with adenocarcinoma treated with 5-fluorouracil, adriamycin, and mitomycin (FAM), nine showed minor histological changes compared with 14 control cases."3.68Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. ( Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR, 1993)
"Ten resected oesophageal adenocarcinomas treated with preoperative chemotherapy--mitomycin-C, ifosfamide, and cisplatin (MIC)--were examined by transmission electron microscopy and their appearance compared with that of 13 concurrent untreated resected oesophageal adenocarcinomas."3.68Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma. ( Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J, 1992)
"25 previously untreated patients with inoperable or metastatic adenocarcinoma of the oesophagus or oesophageal-gastric junction area were treated with ifosfamide 6 g/m2 over 48 hours, combined with mesna 6 g/m2."3.68Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group. ( Kok, TC; Splinter, TA; Tilanus, HW; van der Gaast, A, 1991)
"From April 1982, until February 1984, 29 patients with biopsy-proven and measurable adenocarcinoma of the pancreas were treated with ifosfamide."3.67Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas. ( Ansari, R; Einhorn, LH; Loehrer, PJ; Williams, SD, 1985)
"Twelve patients with stage D2 adenocarcinoma of the prostate were treated with the combination chemotherapy of ifosfamide (2 g/body, i."3.67[Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer]. ( Andoh, M; Fukui, I; Higashi, Y; Horiuchi, S; Kihara, K; Kitahara, S; Oshima, H; Takeuchi, S, 1989)
"Fourteen evaluable patients with gynecologic adenocarcinoma (7 ovarian, 4 endometrial, 2 peritoneal and one breast cancer) were treated with ifosfamide (1 g/m2 X 5 days), adriamycin (50 mg/m2) and cisplatin (50 mg/m2) combined chemotherapy (IAP)."3.67Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin. ( Nagasue, N; Nishida, T, 1988)
"Nineteen patients with hormonal refractory adenocarcinoma of the prostate were treated with ifosfamide (IFM) and the combination of vincristine, ifosfamide and peplomycin (VIP)."3.67[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. ( Ebisui, K; Fujiwara, M; Kobayashi, T; Miyakoda, K; Nakagawa, S; Nakao, M; Nukui, M; Takada, H; Toyoda, K; Watanabe, H, 1989)
"Eleven patients with advanced adenocarcinoma of the prostate were treated with a cyclic alternating chemotherapy (VIP-DMF therapy), consisting of a three-drug combination of vincristine, ifosfamide, and peplomycin; and a three-drug combination of adriamycin, mitomycin C and 5-fluorouracil."3.67[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate]. ( Akagi, T; Hara, M; Nanba, K; Obama, T; Ochi, J; Ozaki, Y; Saegusa, M; Tanahashi, T; Tsushima, T; Yoshimoto, J, 1987)
"Fifty-three patients with inoperable non-small cell bronchial carcinoma were treated at four-weekly intervals with two cytostatic drugs, doxorubicin (50 mg/m2 on day 1) and ifosfamide (2000 mg/m2 on days 1-3)."3.66[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide]. ( Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U, 1983)
" Alternative dosing of glufosfamide plus gemcitabine should be explored."2.75A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma. ( Barrios, CH; Chiorean, EG; Dragovich, T; Gorini, CF; Hamm, J; Jung, DT; Kroll, S; Langmuir, VK; Loehrer, PJ; Tidmarsh, GT, 2010)
"Phase I data indicate that full dose glufosfamide (4,500 mg/m(2)) can be given safely in combination with gemcitabine."2.73A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma. ( Chiorean, EG; Colowick, AB; Dragovich, T; Hamm, J; Jung, DT; Kroll, S; Langmuir, VK; Loehrer, PJ; Tidmarsh, GF, 2008)
"Salvage chemotherapy in advanced ovarian cancer is not yet standardized."2.72Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study. ( Baur, M; Dittrich, C; Fazeny-Doerner, B; Hudec, M; Salzer, H; Sevelda, P, 2006)
"Ifosfamide is an active alkylating agent used in the first-line treatment of NSCLC."2.71Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel. ( Chen, MC; Chen, YM; Lee, CS; Lin, WC; Perng, RP; Shih, JF; Tsai, CM, 2003)
"Secondary objectives were time to disease progression, response rates, evaluation of toxicity, disease-related symptoms, World Health Organization performance status (PS), and quality of life (QoL)."2.71Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. ( Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N, 2003)
"Ifosfamide is an active drug in the treatment of chemotherapy-naive patients with advanced endometrial cancer and its application in currently used (combination) regimens should be considered."2.69Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group. ( Boes, GH; Cervantes, A; Hoesel, G; Pawinski, A; Pecorelli, S; Tumolo, S; van Oosterom, AT, 1999)
"Megestrol acetate 250 mg PO was administered throughout the duration of chemotherapy."2.69A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial. ( Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H, 1998)
"Twenty-five women with advanced breast carcinoma refractory to first-line chemotherapy entered a phase II trial to evaluate the efficacy of ifosfamide and carboplatin."2.68Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma. ( Herman, RL; Kelley, AS; Muggia, FM; Russell, CA; Spicer, DV; Turrill, M, 1995)
"The ongoing phase I study reported here sought to determine the maximum tolerated doses of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and carboplatin when given at specific times in combination with ifosfamide, mesna, and filgrastim."2.68Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results. ( Palackdharry, CS, 1997)
"The early stages of bronchial carcinoma are still a domain of operative treatment."2.68[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. ( Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N, 1995)
"Granulocytopenia was the dose-limiting toxicity."2.68Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. ( Benner, SE; Hong, WK; Huber, MH; Lippman, SM, 1995)
"However, cancers such as ovarian cancer that form huge tumor masses cannot be cured completely with chemotherapy alone."2.66Current role of chemotherapy in the management of ovarian cancer. ( Yakushiji, M, 1987)
" A daily dosage of 50 to 60 mg/kg ifosfamide on 5 consecutive days produced the best results."2.64Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide. ( Brock, N; Burkert, H; Fichtner, E; Schnitker, J, 1976)
"In epithelial ovarian cancer, responses were observed in eight (20%) of 41 evaluable patients, with three (7%) complete responses."2.38Gynecologic Oncology Group studies with ifosfamide. ( Blessing, JA; Homesley, H; Manetta, A; McGuire, W; Sutton, GP, 1992)
"Standard treatment of cervical cancer FIGO stage IB1 is a radical hysterectomy with pelvic lymphadenectomy."1.42Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer. ( Leunen, K; Moerman, P; Neven, P; Salihi, R; Van Limbergen, E; Vergote, I, 2015)
"Downstaging by NAC in IB1 and IB2 cervical cancer before fertility-sparing surgery is still an experimental procedure, but shows some promise."1.40Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. ( Halaska, MJ; Lisy, J; Matecha, J; Pluta, M; Rob, L; Robova, H; Skapa, P, 2014)
"In 20."1.35A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery. ( Doval, DC; Kumar, JV; Rao, R; Rawal, S, 2009)
"The patient died due to brain metastases 20 months after the start of intra-arterial chemotherapy."1.30[A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port]. ( Hasegawa, N; Kazama, A; Kondo, N; Tomita, M, 1999)
"The response rate was higher in squamous cell carcinomas (85%) than adenocarcinomas or adenosquamous carcinomas (67%)."1.30[Neoadjuvant chemotherapy for advanced cervical cancer]. ( Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M, 1999)
"Local control rate for inflammatory breast cancer (IBC) is < 50% with standard chemotherapy-radiotherapy regimen."1.30Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin. ( Boyages, J; Gurney, H; Harnett, P; Kefford, R, 1998)
"These were neuroepithelioma, lymphoma, desmoplastic small-cell tumor, melanoma, and clear-cell sarcoma."1.29Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. ( Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E, 1995)
"Ifosfamide has shown promising single-agent activity in non-small cell lung cancer (NSCLC)."1.28Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. ( Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M, 1992)
"Ifosfamide (IFX) has activity in a number of gynaecological malignancies and was selected for evaluation in this disease."1.28A phase II study of ifosfamide in endometrial cancer. ( Barton, C; Blackledge, G; Buxton, EJ; Meanwell, CA; Mould, JJ, 1990)
"The tumors included 5 squamous cell carcinomas (non keratinizing: 2, keratinizing: 3), two adenosquamous (including one glassy cell carcinoma), one adenocarcinoma (endometrioid type) and one argyrophil cell carcinoma."1.28Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix. ( Arimatsu, T; Izumi, S; Matsumura, T; Nagano, H; Nagasue, N; Nishida, T; Okura, N; Yakushiji, M, 1989)
"Ten patients with reactivated stage D prostatic cancer were treated with the combination therapy of vincristine, ifosfamide and peplomycin (VIP therapy)."1.27[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer]. ( Akiya, T; Katayama, T; Kazama, T; Nakada, T; Umeda, K, 1986)
"The course of 72 patients (36 with squamous carcinoma, 25 with adenocarcinoma, two with alveolar-cell carcinoma and nine with large-cell carcinoma) could be evaluated."1.27[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]. ( Abel, U; Dirks, HP; Drings, P; Grimm, V; Heinrich, S; Kleckow, M; Manke, HG; Queisser, W; Stiefel, P, 1984)
"The most frequent histology was squamous cell carcinoma found in 20 patients."1.27[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985)
"The etoposide combination was tolerated better."1.27Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer. ( Abel, U; Bülzebruck, H; Drings, P; Kleckow, M; Manke, HG; Stiefel, P, 1986)
" Bone marrow suppression was the dose-limiting toxicity and led to dosage modification in 24 patients."1.27A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. ( Coleman, RE; Gallagher, C; Harper, PG; Osborne, R; Rankin, EM; Silverstone, AC; Slevin, ML; Souhami, RL; Tobias, JS; Trask, CW, 1986)
"Ifosfamide was administered to 21 patients with recurrent or disseminated lung cancer at a dose of 4."1.26Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules. ( Costanzi, JJ; Gagliano, R; Hokanson, JA; Loukas, D; Panettiere, FJ, 1978)

Research

Studies (157)

TimeframeStudies, this research(%)All Research%
pre-199043 (27.39)18.7374
1990's63 (40.13)18.2507
2000's34 (21.66)29.6817
2010's16 (10.19)24.3611
2020's1 (0.64)2.80

Authors

AuthorsStudies
Yonemaru, J1
Takahashi, M1
Nara, S1
Ichikawa, H1
Ishigamori, R1
Imai, T1
Hiraoka, N1
Karageorgopoulou, S1
Kostakis, ID1
Gazouli, M1
Markaki, S1
Papadimitriou, M1
Bournakis, E1
Dimopoulos, MA2
Papadimitriou, CA1
Pinkavova, I1
Fischerova, D1
Zikan, M1
Burgetova, A1
Slama, J1
Svarovsky, J1
Dundr, P1
Dusek, L1
Cibula, D1
Ozdemir, O1
Ozdemir, P1
Veral, A1
Uluer, H1
Ozhan, MH1
Ma, K1
Yang, YH1
Yang, X1
Feng, ZY1
Liu, TY1
Wen, HW1
Liao, QP1
Vizza, E1
Corrado, G1
Zanagnolo, V2
Tomaselli, T1
Cutillo, G1
Mancini, E1
Maggioni, A2
Chovanec, M1
Mego, M1
Sycova-Mila, Z1
Obertova, J1
Rajec, J1
Palacka, P1
Mardiak, J1
Robova, H1
Halaska, MJ1
Pluta, M1
Skapa, P1
Matecha, J1
Lisy, J1
Rob, L1
Gakis, G1
Morgan, TM1
Daneshmand, S1
Keegan, KA1
Todenhöfer, T1
Mischinger, J1
Schubert, T1
Zaid, HB1
Hrbacek, J1
Ali-El-Dein, B1
Clayman, RH1
Galland, S1
Olugbade, K1
Rink, M1
Fritsche, HM1
Burger, M1
Chang, SS1
Babjuk, M1
Thalmann, GN1
Stenzl, A1
Efstathiou, JA1
Salihi, R1
Leunen, K1
Van Limbergen, E1
Moerman, P1
Neven, P1
Vergote, I1
Minig, L1
Cárdenas-Rebollo, JM1
Colombo, N1
Tatokoro, M1
Kawakami, S1
Yonese, J1
Fujii, Y1
Okubo, Y1
Yamamoto, S1
Takeshita, H1
Komai, Y1
Ishikawa, Y1
Fukui, I2
Maneo, A1
Chiari, S1
Bonazzi, C1
Mangioni, C1
Li, XP1
Cui, H1
Zhou, JW1
Wei, LH1
Wang, JL1
Zhao, Y1
Wang, Y1
Wang, SJ1
Zhu, HL1
Dong, L1
Zhang, H1
Ciuleanu, TE1
Pavlovsky, AV1
Bodoky, G1
Garin, AM1
Langmuir, VK3
Kroll, S3
Tidmarsh, GT2
Mesa, H1
Rawal, A1
Rezcallah, A1
Iwamoto, C1
Niehans, GA1
Druck, P1
Gupta, P1
Kumar, JV1
Doval, DC1
Rao, R1
Rawal, S1
Chiorean, EG2
Dragovich, T2
Hamm, J2
Barrios, CH1
Gorini, CF1
Jung, DT2
Loehrer, PJ6
Chu, P1
Lu, CH1
Sheng, XG1
Zhou, CX1
Li, DP1
DU, XL1
Liu, NF1
Gong, L1
Lou, JY1
Wang, P1
Zhang, JW1
Liu, H1
Peng, ZL1
Wang, PL1
Cheng, YB1
Kuerban, G1
Vercellino, GF1
Piek, JM1
Schneider, A1
Köhler, C1
Mangler, M1
Speiser, D1
Chiantera, V1
Vitobello, D1
Siesto, G1
Pirovano, C1
Ieda, N1
Hervonen, P1
Lehtinen, T1
Tammela, TL1
Kellokumpu-Lehtinen, P1
Blot, E1
Decaudin, D1
Veyradier, A1
Bardier, A1
Zagame, OL1
Pouillart, P2
Marx, G1
Lewis, C1
Hall, K1
Levi, J1
Ackland, S1
Siersema, PD1
Hage, M1
van der Gaast, A2
van Dekken, H1
Kok, TC2
Tilanus, HW2
Kuipers, EJ1
Gebbia, V1
Galetta, D1
Caruso, M1
Verderame, F1
Pezzella, G1
Valdesi, M1
Borsellino, N1
Pandolfo, G1
Durini, E1
Rinaldi, M1
Loizzi, M1
Gebbia, N1
Valenza, R1
Tirrito, ML1
Varvara, F1
Colucci, G1
Chen, YM1
Shih, JF1
Lee, CS1
Chen, MC1
Lin, WC2
Tsai, CM2
Perng, RP2
Salmons, B5
Löhr, M4
Günzburg, WH5
Danson, S1
Middleton, MR1
O'Byrne, KJ1
Clemons, M1
Ranson, M1
Hassan, J1
Anderson, H1
Burt, PA1
Fairve-Finn, C1
Stout, R1
Dowd, I1
Ashcroft, L2
Beresford, C1
Thatcher, N3
Fujita, A4
Ohkubo, T1
Hoshino, H1
Takabatake, H3
Tagaki, S3
Sekine, K4
Abe, S1
Briasoulis, E1
Pavlidis, N1
Terret, C1
Bauer, J1
Fiedler, W1
Schöffski, P1
Raoul, JL1
Hess, D1
Selvais, R1
Lacombe, D1
Bachmann, P1
Fumoleau, P1
Junker, K1
Müller, KM1
Abker, S1
Bosse, U1
Klinke, F2
Thomas, M1
Boutemy, M1
Mispelaere, D1
Krzisch, C1
Jounieaux, V1
Vrdoljak, E1
Boraska Jelavic, T1
Saratlija-Novakovic, Z1
Hamm, W1
Baur, M1
Fazeny-Doerner, B1
Hudec, M1
Sevelda, P1
Salzer, H1
Dittrich, C1
Markman, M1
Galsky, MD1
Iasonos, A1
Mironov, S1
Scattergood, J1
Donat, SM1
Bochner, BH1
Herr, HW1
Russo, P1
Boyle, MG1
Bajorin, DF1
Colowick, AB1
Tidmarsh, GF1
Booton, R1
Ward, T1
Morris, J1
Heighway, J1
Han, JQ1
Han, CY1
Bi, YH1
Arai, H1
Rino, Y1
Yamanaka, S2
Yukawa, N1
Wada, N1
Kudo, M1
Watanuki, Y1
Fukumura, H1
Nakajima, K1
Oshiro, H1
Masuda, M1
Drings, P4
Stiefel, P3
Dirks, HP1
Grimm, V1
Kleckow, M2
Manke, HG3
Queisser, W1
Abel, U2
Heinrich, S1
Saiers, JH2
Slavik, M2
Harrison, EF1
Hawke, JE1
Hunter, HL1
Costanzi, JJ3
Morgan, LR2
Plotkin, D1
Tucker, WG1
Worrall, PM1
Hokanson, J1
Holoye, PY2
Anderson, T2
Duelge, J2
Hansen, RM2
Ritch, PS2
Bakowski, MT1
Crouch, JC1
Joss, RA1
Cavalli, F1
Goldhirsch, A2
Mermillod, B1
Brunner, KW2
Nishida, T6
Oda, T2
Sugiyama, T2
Iwanaga, S1
Katabuchi, H2
Araki, T2
Struck, RF1
Dykes, DJ1
Corbett, TH1
Suling, WJ1
Trader, MW1
Williams, SD3
Einhorn, LH3
Matthiessen, W1
Stempinski, E1
Göbel, D1
Thalmann, U1
Kohno, I1
Kazuta, M1
Miyao, J1
Kunimi, N1
Kawamoto, M1
Tanimura, T1
Fujiwara, K1
Sekiba, K1
Satomi, Y1
Kawamura, N1
Yakushiji, M4
Tsunawaki, A1
Nishimura, H1
Natsuaki, Y1
Inoue, T1
Kato, T2
König, HJ1
Hartwich, G1
Benner, SE1
Lippman, SM1
Huber, MH1
Hong, WK2
Wagner, W1
von Eiff, M1
Micke, O1
Rübe, C1
Willich, N1
Motzer, RJ1
Rodriguez, E1
Reuter, VE1
Bosl, GJ1
Mazumdar, M1
Chaganti, RS1
Turrill, M1
Spicer, DV1
Kelley, AS1
Herman, RL1
Russell, CA1
Muggia, FM1
Fanning, J1
Ladd, C1
Hilgers, RD1
Sutton, GP4
Blessing, JA4
Homesley, HD1
McGuire, WP2
Adcock, L1
Hartley, JM1
Hansen, L1
Harland, SJ1
Nicholson, PW1
Pasini, F1
Souhami, RL2
Ushiyama, T1
Ihara, H1
Kurita, Y1
Kageyama, S1
Ueda, D1
Mugiya, S1
Yamaguchi, Y1
Nakano, M1
Suzuki, K1
Kawabe, K1
Wils, JA1
Kok, T1
Wagener, DJ1
Francois, E1
Selleslags, J1
Duez, N2
Darnton, SJ5
Allen, SM2
Edwards, CW1
Matthews, HR4
DiSaia, PJ1
Dorval, T1
Beuzeboc, P1
Garcia-Giralt, E1
Jouve, M1
Livartowski, A1
Palangie, T1
Jenner, K1
Steyn, RS1
Ferry, DR2
Duffy, JP1
Cullen, MH1
Souquet, PJ1
Fournel, P1
Bohas, CH1
Fortune, IC1
Chatte, G1
Di Costanzo, F1
Tagliaventi, M1
Carlini, P1
Zironi, S1
Mazzocchi, B1
Bella, M1
Donati, D1
Acito, L1
Maggian, P1
Angiona, S1
Nardi, M1
Della Giulia, M1
Pollera, CF1
Marolla, P1
Ruggeri, EM1
Iacovelli, A1
Atlante, G1
Calabresi, F1
Perkins, JB1
Effenbein, GJ1
Fields, KK1
Williamson, SK1
Wolf, MK1
Eisenberger, MA1
O'Rourke, MA1
Brannon, W1
Crawford, ED1
Vansteenkiste, J1
Vandebroek, J1
Mariën, S1
Roex, L1
Bertrand, P1
Bockaert, J1
De Beukelaar, T1
Deman, R1
De Muynck, P1
Ulrichts, H1
Lokich, J1
Anderson, N1
Moore, C1
Bern, M1
Coco, F1
Dow, E1
Poorter, RL1
Bakker, PJ1
Huizing, MT1
Taat, CW1
Rietbroek, RC1
Gouma, DJ1
Rauws, EA1
Veenhof, CH1
Teicher, BA1
Holden, SA1
Goff, DA1
Wright, JE1
Tretyakov, O1
Ayash, LJ1
Scagliotti, GV1
Ricardi, U1
Crinó, L1
Maranzano, E1
De Marinis, F1
Morandi, MG1
Meacci, L1
Marangolo, M1
Emiliani, E1
Rosti, G1
Figoli, F1
Bolzicco, G1
Masiero, P1
Gentile, A1
Tonato, M1
DeMars, LR1
Moore, D1
Burke, TW1
Grendys, EC1
Dreicer, R1
Propert, KJ1
Roth, BJ1
Rodenhuis, S1
Boerrigter, L1
Top, B1
Slebos, RJ1
Mooi, WJ1
van't Veer, L1
van Zandwijk, N1
Palackdharry, CS1
Witschi, H1
Espiritu, I1
Peake, JL1
Wu, K1
Maronpot, RR1
Pinkerton, KE1
Kyriakakis, Z1
Kostakopoulos, A1
Karayiannis, A1
Sofras, F1
Zervas, A1
Giannopoulos, A1
Dimopoulos, C1
Malhaire, JP1
Labat, JP1
Simon, H1
Le Maux, H1
Spindler, P1
Lucas, B1
Lamezec, B1
Haberkorn, U1
Krems, B1
Gerlach, L1
Bachert, P1
Morr, I1
Wiessler, M1
van Kaick, G1
Gurney, H2
Harnett, P1
Kefford, R1
Boyages, J1
Kodama, J1
Ikuhashi, H1
Hongo, A1
Mizutani, Y1
Miyagi, Y1
Yoshinouchi, M1
Kobashi, Y1
Okuda, H1
Kudo, T1
Karle, P4
Müller, P3
Renz, R1
Jesnowski, R2
Saller, R1
von Rombs, K1
Nizze, H3
Liebe, S3
Levitan, N1
Dowlati, A1
Craffey, M1
Tahsildar, H1
MacKay, W1
McKenney, J1
Remick, SC1
Stange, J1
Mitzner, S1
Nebe, B1
Waller, CF1
von Lintig, F1
Daskalakis, A1
Musahl, V1
Lange, W1
Kondo, N1
Tomita, M1
Hasegawa, N1
Kazama, A1
Pawinski, A1
Tumolo, S1
Hoesel, G1
Cervantes, A1
van Oosterom, AT1
Boes, GH1
Pecorelli, S1
Campisi, C1
Fabi, A1
Papaldo, P1
Tomao, S1
Massidda, B1
Zappala, A1
Ionta, MT1
Cognetti, F1
Kusnierczyk, H1
Pajtasz-Piasecka, E1
Radzikowski, C1
Chen, Y1
Yang, KY1
Wu, HW1
Whang-Peng, J1
Renner, M2
Hoffmeyer, A1
Kröger, J1
Freund, M1
Hain, J1
Holle, A1
Knöfel, WT1
Saller, RM1
Wagner, T1
Hauenstein, K1
Saghatchian, M1
Fizazi, K1
Borel, C1
Ducreux, M1
Ruffié, P1
Le Chevalier, T1
Théodore, C1
Blohmer, JU1
Paepke, S1
Böhmer, D1
Ernhardt, B1
Sehouli, J1
Elling, D1
Lichtenegger, W1
Archer, VR1
Mulholland, PJ1
Stocken, DD1
Tilignac, T1
Temparis, S1
Combaret, L1
Taillandier, D1
Pouch, MN1
Cervek, M1
Cardenas, DM1
Le Bricon, T1
Debiton, E1
Samuels, SE1
Madelmont, JC1
Attaix, D1
Gagliano, R1
Loukas, D1
Panettiere, FJ1
Hokanson, JA1
Issell, BF1
Valdivieso, M1
Hersh, EM1
Richman, S1
Gutterman, JU1
Bodey, GP1
Schnitker, J1
Brock, N1
Burkert, H1
Fichtner, E1
Tay, SK1
Lai, FM1
Soh, LT1
Ho, TH1
Ang, PT1
Au, E1
Shirinian, M1
Lee, JS1
Dhingra, HH1
Greenberg, J1
Hirabayashi, K1
Okada, E1
Nakazuma, Y1
Akamatsu, Y1
Sezaki, H1
Ohta, M1
Nakanishi, Y1
Antonakopoulos, GN1
Newman, J1
Hojo, K1
Kumasaka, Y1
Nishiyama, S1
Higashihara, T1
Oku, Y1
Okada, M1
Kajiyama, K1
Manetta, A1
Homesley, H1
McGuire, W1
de Campos, ES1
Dodwell, D1
Kamthan, A1
Ohnoshi, T3
Ueoka, H3
Kodani, T1
Kamei, H1
Kimura, I1
Buxton, EJ2
Saunders, N1
Blackledge, GR1
Kelly, K1
Redman, CW1
Monaghan, J1
Paterson, ME1
Luesley, DM1
Vannier, JP1
Flamant, F1
Hemet, J1
Caillaud, JM1
Gruner, M1
Bachy, B1
Lefur, R1
Lemerle, J1
Tron, P1
Cerny, T1
Martinelli, G1
Terrier, F1
Joss, R1
Fey, MF1
Küpfer, A1
Klein, HO1
Golbach, G1
Voigt, P1
Coerper, C1
Bernhardt, C1
Splinter, TA1
Sasaki, H1
Mori, T1
Nakajima, S1
Inoue, Y1
Honda, R1
Asakawa, M1
Suzuki, A1
Ulmer, W1
Anderson, NR1
Tandon, DS1
Abad, A1
Rosell, R1
Barnadas, A1
Carles, J1
Ribelles, N1
Solano, V1
Fujii, M1
Segawa, Y1
Matsutomo, S1
Genba, K1
Paccagnella, A1
Favaretto, A1
Brandes, A1
Ghiotto, C1
Fornasiero, A1
Volpi, A1
Pappagallo, G1
Festi, G1
Cipriani, A1
Vinante, O1
Barton, C1
Blackledge, G1
Mould, JJ1
Meanwell, CA1
Yoshimoto, J2
Nasu, Y1
Akagi, T2
Obama, T2
Tsushima, T2
Ozaki, Y2
Matsumura, Y1
Ohmori, H1
Kazama, T1
Katayama, T1
Umeda, K1
Akiya, T1
Nakada, T1
Ochi, J1
Tanahashi, T1
Nanba, K1
Saegusa, M1
Hara, M1
Nukui, M1
Nakao, M1
Nakagawa, S1
Toyoda, K1
Takada, H1
Ebisui, K1
Watanabe, H1
Miyakoda, K1
Kobayashi, T1
Fujiwara, M1
Nagasue, N2
Arimatsu, T1
Nagano, H1
Izumi, S1
Okura, N1
Matsumura, T1
Numata, T1
Kawahara, S2
Nishii, K1
Yonei, T2
Yamashita, H2
Ishii, J2
Moritaka, T1
Kiura, K1
Meier, W1
Eiermann, W1
Stieber, P1
Fateh-Moghadam, A1
Hepp, H1
Wils, J1
Bleiberg, H1
Buyse, M1
Wagener, DT1
Splinter, T1
Veenhof, C1
Herben, M1
Takeuchi, S1
Higashi, Y1
Andoh, M1
Kihara, K1
Kitahara, S1
Horiuchi, S1
Oshima, H1
Ardizzoni, A1
Fusco, V1
Gulisano, M1
Pronzato, P1
Baracco, F1
Capaccio, A1
Pastorino, G1
Nosenzo, M1
Felletti, R1
Fabiano, F1
Hiraki, S1
Tamura, T1
Tamai, M1
Egawa, T1
Becker, H1
Bülzebruck, H2
Djawid, N1
Ruchalla, E1
Tessen, HW1
Satoh, H1
Yano, H1
Naitoh, T1
Suyama, T1
Takahashi, N1
Kameyama, M1
Satoh, T1
Ohtsuka, M1
Yoshizawa, Y1
Hasegawa, S1
Gatzemeier, U1
Hossfeld, DK1
Radenbach, D1
Zschaber, R1
Nichols, CR1
Coleman, RE1
Harper, PG1
Gallagher, C1
Osborne, R1
Rankin, EM1
Silverstone, AC1
Slevin, ML1
Tobias, JS1
Trask, CW1
Kamura, N1
Ansari, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Pancreatic Cancer[NCT00005053]Phase 235 participants (Actual)Interventional1999-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for ifosfamide and Adenocarcinoma, Basal Cell

ArticleYear
[Clinical features of patients with metastasis in phalanges as first symptom of primary lung cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcino

2007
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm

1983
New agents in non-small cell lung cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti

1984
Gynecologic Oncology Group studies with ifosfamide.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 12

    Topics: Adenocarcinoma; Carcinoma; Clinical Trials, Phase II as Topic; Endometrial Neoplasms; Female; Genita

1992

Trials

60 trials available for ifosfamide and Adenocarcinoma, Basal Cell

ArticleYear
Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    BMC cancer, 2017, Jun-28, Volume: 17, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carc

2017
[Efficacy and tolerability of the combination of oxaliplatin, ifosfamide, and epirubicin in treatment of recurrent or platinum-resistant ovarian epithelial cancer patients].
    Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin;

2008
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Deoxycytidine; Fe

2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma.
    American journal of clinical oncology, 2010, Volume: 33, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female;

2010
[Gemcitabine based combination chemotherapy, a new salvage regimen for recurrent platinum resistant epithelial ovarian cancer].
    Zhonghua fu chan ke za zhi, 2010, Volume: 45, Issue:11

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistanc

2010
A randomised dose-finding phase II study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC).
    Journal of experimental & clinical cancer research : CR, 2002, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Disease Progression; Dose-R

2002
Phase I study of docetaxel plus ifosfamide in patients with advanced cancer.
    British journal of cancer, 2002, Oct-07, Volume: 87, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Respons

2002
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospe
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell;

2003
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy

2003
Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial.
    Journal of gastroenterology, 2003, Volume: 38 Suppl 15

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Cell Transplantation; Cytochrome P-450 CYP2B1; Do

2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Cancer, 2003, Aug-01, Volume: 98, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; C

2003
Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
    British journal of cancer, 2003, Sep-15, Volume: 89, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma

2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:16

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Fema

2003
Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study.
    Cancer investigation, 2006, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female;

2006
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Urology, 2007, Volume: 69, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biop

2007
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic

2008
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell;

2007
Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cl

1982
Use and safety of high-dose ifosfamide.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyc

1982
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Cancer treatment reviews, 1983, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm

1983
New agents in non-small cell lung cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Anti

1984
Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
    Seminars in oncology, 1995, Volume: 22, Issue:5 Suppl 12

    Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin

1995
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1995, Volume: 171, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronc

1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma.
    Cancer investigation, 1995, Volume: 13, Issue:2

    Topics: Adenocarcinoma; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl

1995
Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer.
    Gynecologic oncology, 1995, Volume: 56, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

1995
Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
    Cancer, 1994, Mar-01, Volume: 73, Issue:5

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Combined Modality Therapy; Endometrial Neoplasms; Female; H

1994
[Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Admin

1993
Phase II trial with ifosfamide in pancreatic cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Female; Humans; Ifosfamide; Male; Middle Aged; Pancreatic Neoplasms

1993
Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Gynecologic oncology, 1993, Volume: 49, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Female; Humans; Ifosfamide; Mesna; Middle Aged; Uterine Cerv

1993
[Treatment of cancers of the ovary. Phase II trial of increase of the dose of cisplatin].
    Presse medicale (Paris, France : 1983), 1993, Jan-30, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin;

1993
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant;

1996
Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:2 Suppl 5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

1996
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
    American journal of clinical oncology, 1996, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; H

1996
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols;

1996
Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:3 Suppl 6

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylatin

1996
Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.
    American journal of clinical oncology, 1996, Volume: 19, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; B

1996
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell;

1995
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
    The Journal of infusional chemotherapy, 1996,Winter, Volume: 6, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Che

1996
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma,

1996
A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Gynecologic oncology, 1996, Volume: 63, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Endometrial Neoplasms; Fe

1996
Vinblastine, ifosfamide, and gallium nitrate--an active new regimen in patients with advanced carcinoma of the urothelium. A phase II trial of the Eastern Cooperative Oncology Group (E5892).
    Cancer, 1997, Jan-01, Volume: 79, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional

1997
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carci

1997
Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    The Journal of urology, 1997, Volume: 158, Issue:2

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic A

1997
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Ca

1998
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin;

1999
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group.
    European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 86, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Endometrial Neopla

1999
Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44 Suppl

    Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Proto

1999
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.
    Lung cancer (Amsterdam, Netherlands), 2000, Volume: 29, Issue:2

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro

2000
Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma.
    Lancet (London, England), 2001, May-19, Volume: 357, Issue:9268

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Transplantation; Cytochrome P-450 CYP2B1; Dose-

2001
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differe

2001
[Adjuvant chemotherapy of cervix carcinoma--results of a phase II study].
    Zentralblatt fur Gynakologie, 2001, Volume: 123, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin

2001
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2001, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp

2001
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
    Cancer treatment reports, 1978, Volume: 62, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Bacterial Vaccines; Body Weight; Carcinoma, Squamous Cell; Clinical Tri

1978
Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Arzneimittel-Forschung, 1976, Volume: 26, Issue:10

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Child; Clinical Trials as Topic; Cyclopho

1976
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2

    Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No

1990
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study.
    Journal of cancer research and clinical oncology, 1991, Volume: 117 Suppl 4

    Topics: Adenocarcinoma; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ifosfami

1991
Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.
    Journal of cancer research and clinical oncology, 1991, Volume: 117 Suppl 4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; C

1991
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Cancer, 1990, Jun-15, Volume: 65, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1990
Current role of chemotherapy in the management of ovarian cancer.
    Seminars in surgical oncology, 1987, Volume: 3, Issue:1

    Topics: Actuarial Analysis; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cis

1987
Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi

1987

Other Studies

95 other studies available for ifosfamide and Adenocarcinoma, Basal Cell

ArticleYear
A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020, Volume: 20, Issue:3

    Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cis

2020
Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2013, Volume: 42, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

2013
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carb

2013
[Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2013, Dec-18, Volume: 45, Issue:6

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamou

2013
Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
    Gynecologic oncology, 2014, Volume: 133, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

2014
Adenocarcinoma of the rete testis - a rare case of testicular malignancy.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Filgrastim; Granulocyte C

2014
Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer.
    Gynecologic oncology, 2014, Volume: 135, Issue:2

    Topics: Abortion, Spontaneous; Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Proto

2014
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carb

2015
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Gynecologic oncology, 2015, Volume: 139, Issue:3

    Topics: Abortion, Missed; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin

2015
Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:9

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis

2016
Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus.
    International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; F

2008
Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Gynecologic oncology, 2008, Volume: 111, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Che

2008
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
    International journal of clinical oncology, 2009, Volume: 14, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; D

2009
A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou

2009
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 117, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S

2012
The clinical characteristic differences between thrombosis-related edema and lymphedema following radiotherapy or chemoradiotherapy for patients with cervical cancer.
    Journal of radiation research, 2012, Volume: 53, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy

2012
Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
    Gynecologic oncology, 2012, Volume: 126, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squ

2012
Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2013, Volume: 39, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom

2013
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemothe

2002
Cure of Barrett's carcinoma by ifosfamide chemotherapy.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:11

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Barrett Esophagus; Esophageal Neoplasms; Fo

2002
[Cellular changes in non-small cell lung cancer after neoadjuvant therapy].
    Der Pathologe, 2004, Volume: 25, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Ce

2004
[Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma].
    Revue des maladies respiratoires, 2005, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin

2005
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in the treatment of locally advanced adenocarcinoma or adenosquamous carcinoma of the cervix uteri.
    European journal of gynaecological oncology, 2005, Volume: 26, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom

2005
Another example of the highly variable clinical course of recurrent/resistant/persistent ovarian cancer.
    Cancer investigation, 2006, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Drug Resistan

2006
[A case of primary lung adenocarcinoma accompanied by Ewing's sarcoma successfully treated with ifosfamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Humans; Ifosfamide; Lung Neoplasms; Male; Middle

2008
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].
    Deutsche medizinische Wochenschrift (1946), 1984, Jul-06, Volume: 109, Issue:27

    Topics: Adenocarcinoma; Adult; Aged; Alopecia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; C

1984
Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Veterinary and human toxicology, 1981, Volume: 23, Issue:Suppl 1

    Topics: Acetylcysteine; Adenocarcinoma; Administration, Oral; Carcinoma; Carcinoma, Small Cell; Carcinoma, S

1981
Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
    Seminars in oncology, 1982, Volume: 9, Issue:4 Suppl 1

    Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administrati

1982
[Evaluation of cancer chemotherapy in primary ovarian cancer in rats--observation of histological effect by light and electron microscopy].
    Nihon Sanka Fujinka Gakkai zasshi, 1984, Volume: 36, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Chromatin; Connective Tissue; Cyclophosph

1984
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    British journal of cancer, 1983, Volume: 47, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide;

1983
Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetylcysteine; Acrolein; Adenocarcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Cystitis; Dose

1983
Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetylcysteine; Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Dose-Response Rela

1983
N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Seminars in oncology, 1983, Volume: 10, Issue:1 Suppl 1

    Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combin

1983
[Combined cytostatic chemotherapy of advanced non-small-cell bronchial carcinoma with doxorubicin and ifosfamide].
    Deutsche medizinische Wochenschrift (1946), 1983, May-27, Volume: 108, Issue:21

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophos

1983
[Clinical studies of ifosfamide for gynecological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:5

    Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Female; Humans; I

1983
[Pulmonary metastasis of renal cell carcinoma].
    Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil;

1983
[Heterotransplantation of malignant human tumor of the urogenital system. Part TV. Experimental treatment using several antineoplastic agents of human renal cell tumor transplantable to nude mice].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1982, Volume: 73, Issue:11

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Humans; Ifosfamide; Kidney Neoplas

1982
Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Acta obstetrica et gynaecologica Japonica, 1981, Volume: 33, Issue:7

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Cyclophosphamide; Cystadenocarcinoma; Drug Administration S

1981
[Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1980, Dec-26, Volume: 105, Issue:52

    Topics: Adenocarcinoma; Bone Neoplasms; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Neoplasms; Lung

1980
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma

1995
Metabolism of ifosfamide during a 3 day infusion.
    British journal of cancer, 1994, Volume: 69, Issue:5

    Topics: Adenocarcinoma; Chromatography, Thin Layer; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors

1994
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
    Journal of clinical pathology, 1993, Volume: 46, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

1993
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
    Journal of clinical pathology, 1995, Volume: 48, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Tr

1995
Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; H

1995
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro

1996
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Gene Ex

1997
The carcinogenicity of environmental tobacco smoke.
    Carcinogenesis, 1997, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Adenoma; Administration, Inhalation; Animals; Antineoplastic Agents; Biomarkers; But

1997
One case of Stewart-Treves syndrome successfully treated at two years by chemotherapy and radiation therapy in a 73-year-old woman.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:4

    Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic

1997
[Efficacy of systemic chemotherapy in adenocarcinoma of the lung with pleuritis carcinomatosa].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin

1997
Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments.
    Magnetic resonance in medicine, 1998, Volume: 39, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Drug Monitoring; Drug Screening Assays,

1998
Inflammatory breast cancer: enhanced local control with hyperfractionated radiotherapy and infusional vincristine, ifosfamide and epirubicin.
    Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality

1998
[Neoadjuvant chemotherapy for advanced cervical cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou

1999
Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy.
    Advances in experimental medicine and biology, 1998, Volume: 451

    Topics: Adenocarcinoma; Animals; Biotransformation; Capsules; Cell Line; Cell Survival; Cell Transplantation

1998
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.
    Gene therapy, 1998, Volume: 5, Issue:8

    Topics: Adenocarcinoma; Animals; Capsules; Cats; Combined Modality Therapy; Cytochrome P-450 CYP2B1; Genetic

1998
[A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasm

1999
Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model.
    Medical oncology (Northwood, London, England), 1999, Volume: 16, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Colonic Neoplasms; Combined Modality The

1999
Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
    Chest, 2001, Volume: 119, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Tri

2001
Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide.
    Cancer gene therapy, 2001, Volume: 8, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Cats; Cell Line; Cells, Cultu

2001
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
    Cancer research, 2002, May-15, Volume: 62, Issue:10

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cachexia; Cisplatin; Colonic Neoplasms; Cysteine End

2002
Ifosfamide in the treatment of recurrent or disseminated lung cancer: a phase II study of two dose schedules.
    Cancer, 1978, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophos

1978
Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1992, Volume: 32, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S

1992
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcin

1992
[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
    Nihon Sanka Fujinka Gakkai zasshi, 1992, Volume: 44, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents;

1992
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
    Journal of clinical pathology, 1992, Volume: 45, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplat

1992
[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin;

1992
Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:5

    Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1991
The potential for adjuvant therapy in early-stage cervical cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B

1990
Pancreatoblastoma: response to chemotherapy.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool;

1991
Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Ifosfam

1991
[Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1991
Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosph
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1991, Volume: 167, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Biophysical Phenomena; Biop

1991
Ifosfamide extrapyramidal neurotoxicity.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adenocarcinoma; Basal Ganglia Diseases; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Large B-Cell,

1991
5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bili

1991
[Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung

1990
A phase II study of ifosfamide in endometrial cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Ifosfamide;

1990
[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with advanced stage D adenocarcinoma of the prostate].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1985, Volume: 76, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Humans;

1985
[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Hu

1986
[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug A

1987
[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin;

1989
Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S

1989
[Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; D

1989
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
    Geburtshilfe und Frauenheilkunde, 1989, Volume: 49, Issue:12

    Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumo

1989
An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreas. EORTC Gastrointestinal Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Epirub

1989
[Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:9

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Human

1989
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1987
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce

1988
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Onkologie, 1988, Volume: 11 Suppl 2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun

1988
[A case of retrocecal appendicitis occurrence during effective chemotherapy in lung cancer].
    Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:3

    Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Bone Marrow;

1989
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
    Strahlentherapie, 1985, Volume: 161, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic

1985
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
    Onkologie, 1985, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug

1985
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell;

1986
Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin.
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin;

1988
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Ifosfamide;

1986
[Cancer chemotherapy model using an autochthonous ovarian cancer in rats].
    Nihon Gan Chiryo Gakkai shi, 1985, Aug-20, Volume: 20, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Cisplatin; Female; Ifosfamide; Ovarian Ne

1985
Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:3

    Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Mid

1985